reviewTop 1% cited

Guidelines on nicotine dose selection for in vivo research

Psychopharmacology · 2006 · Vol. 190(3) · pp. 269–319

Shannon G. Matta✉(University of Tennessee Health Science Center)David J.K. Balfour(University of Dundee)Neal L. Benowitz(University of California, San Francisco)R. Thomas Boyd(The Ohio State University)Jerry J. Buccafusco(Augusta University)Anthony R. Caggiula(University of Pittsburgh)Caroline Craig(University of California, San Diego)Allan C. Collins(University of Colorado Boulder)M. Imad Damaj(Virginia Commonwealth University Medical Center)Eric C. Donny(University of Pittsburgh)Phillip S. GardinerSharon R. Grady(University of Colorado Boulder)Ulrike Heberlein(University of California, San Francisco)Sherry Leonard(University of Colorado Health)Edward D. Levin(Duke University Hospital)Ronald J. Lukas(Barrow Neurological Institute)Athina Markou(University of California, San Diego)Michael J. Marks(University of Colorado Boulder)Sarah E. McCallum(Parkinson's Institute and Clinical Center)Neeraja Parameswaran(Parkinson's Institute and Clinical Center)Kenneth A. Perkins(University of Pittsburgh)Marina R. Picciotto(Yale University)Maryka Quik(Parkinson's Institute and Clinical Center)Jed E. Rose(Duke University Hospital)Adrian Rothenfluh(University of California, San Francisco)William R Schafer(University of California, San Diego)Ian P. Stolerman(King's College London)Rachel F. Tyndale(University of Toronto)Jeanne M. Wehner(University of Colorado Boulder)Jeffrey M. Zirger(The Ohio State University)